ADEOYE OLUKOTUN - 13 Sep 2021 Form 4 Insider Report for ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Role
Director
Signature
/s/Adeoye Olukotun
Issuer symbol
ARWR
Transactions as of
13 Sep 2021
Net transactions value
-$318,800
Form type
4
Filing time
14 Sep 2021, 17:25:27 UTC
Previous filing
12 May 2021
Next filing
04 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARWR Common Stock Sale $143,460 -2,250 -16% $63.76 11,750 13 Sep 2021 Direct F1, F2
transaction ARWR Common Stock Sale $175,340 -2,750 -23% $63.76 9,000 13 Sep 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The sale was made to generate proceeds to cover the tax liability incident to the vesting of restricted stock units.
F2 Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.